Margery Ma

Title: Margery Ma: Innovator in Immunology

Introduction

Margery Ma is a notable inventor based in W. Roxbury, MA (US). She has made significant contributions to the field of immunology, particularly through her innovative research and patent work. Her expertise and dedication have led to advancements that may impact the treatment of various immune-related conditions.

Latest Patents

Margery Ma holds a patent for "Methods and compositions for modulating interleukin-21 receptor activity." This patent describes methods and compositions that utilize agonists or antagonists of interleukin-21 (IL-21) or its receptor (IL-21R) to modulate immune responses. The patent outlines how IL-21/IL-21R antagonists can induce immune suppression in vivo, which may be beneficial for treating or preventing immune cell-associated pathologies, including transplant rejection and autoimmune disorders. Conversely, IL-21/IL-21R agonists can enhance immune responses, potentially serving as adjuvants in vaccines for cancer and infectious diseases.

Career Highlights

Margery Ma is associated with Genetics Institute, Inc., where she has been able to apply her research in a practical setting. Her work has not only contributed to scientific knowledge but also has the potential to lead to therapeutic applications that can improve patient outcomes.

Collaborations

Throughout her career, Margery has collaborated with esteemed colleagues, including Laura L. Carter and Beatriz M. Carreno. These collaborations have likely enriched her research and expanded the impact of her work in the field of immunology.

Conclusion

Margery Ma's innovative contributions to immunology, particularly through her patent on modulating interleukin-21 receptor activity, highlight her role as a significant inventor in the field. Her work has the potential to influence treatments for various immune-related conditions, showcasing the importance of innovation in medical research.